Release Date: November 11, 2017
Expiration date: May 11, 2018
Estimated Time to Complete Activity: 1.0 hour  
                                           

CME ACCREDITATION AND DESIGNATION

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.

 

CME for MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

OVERVIEW

This CME program will focus on existing and emerging evidence supporting the execution of chronic total occlusion (CTO) percutaneous revascularization, or CTO PCI. Included in the program will be a review of current evidence from clinical trials and registries of CTO PCI, including DECISION CTO, Euro CTO, OPEN CTO, and PERSPECTIVE. Discussion will also explore barriers to continued uptake of CTO PCI as well as novel approaches for maximizing clinically meaningful outcomes among patients receiving CTO PCI.

LEARNING OBJECTIVES

By the end of this program, participants should be able to:

1) Describe limitations in the clinical evidence supporting CTO PCI

2) Identify new evidence and novel approaches for CTO PCI

3) Describe findings, limitations, and significance of recent CTO PCI trials

TARGET AUDIENCE

This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other healthcare professionals.

ACTIVITY EVALUATION

Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.

DISCLOSURE STATEMENT

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.

FACULTY DISCLOSURE SUMMARY

KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit

David E. Kandzari: (G/R) (C/H/S) Medtronic

J. Aaron Grantham: (G/R) (C/H/S) Boston Scientific, (C/H/S) Abbott Vascular, Vascular Solutions, St. Jude Medical, Asahai-Intecc, (E) Corindus, Insysiv Inc

Nicholas J. Lembo: (C/H/S) Abbott Vascular, Boston Scientific, Medtronic

 

Planning Committee

Robert Blanco (Planner)
(S) Cardiovascular Research Foundation

ACTIVITY SPONSORSHIP AND SUPPORT

This program is sponsored by the Cardiovascular Research Foundation. It is supported through educational grants from Medtronic Inc. and was developed without influence from commercial supporters. 

HOW TO RECEIVE CME CREDIT

To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Robert Blanco at rblanco@crf.org .